Sputnik Lite vaccine can be launched in India by December, up to 70 percent effective against Delta variant
Anti-Covid-19 vaccine Sputnik Lite can be launched in India by December. Kirill Dmitriev, CEO of Russian Direct Investment Fund has given this information. Russia claims that Sputnik Light is up to 70 percent effective against the Delta variant of Corona in the first three months of its installation. According to the Russian administration, the analysis done on Sputnik Light was based on data received from 28 thousand participants.
Sputnik light COVID vaccine to be launched in India by December: Kirill Dmitriev, CEO, Russian Direct Investment Fund pic.twitter.com/Ybjmsi6yfS
— ANI (@ANI) November 24, 2021
In the month of October, the government allowed the export of domestically manufactured Russian single-dose Kovid-19 vaccine Sputnik Lite. According to the report of news agency PTI, Indian pharmaceutical company Hetero Biopharma Limited was given permission to export 4 million doses of Sputnik Lite to Russia. Russian Ambassador Nikolay Kudshev had urged the Indian government to allow the export of Sputnik lights.
At present, this vaccine has not yet been approved for emergency use in India. Hetero Biopharma manufactures Sputnik Light in the country. The Russian vaccine Sputnik Lite is similar to Component-1 of Sputnik V. India’s drug regulator approved the emergency use of Sputnik V in April. Since then it is being used in the anti-Covid-19 vaccination campaign in India.
It is worth mentioning that in the month of September, the Drugs Controller General of India (DCGI) had given permission for the third phase trial of Russia’s Sputnik Light Vaccine in the country. Sputnik Lite is a single dose vaccine, after which no further doses are needed. At present, two doses of the vaccine being used in the country have to be administered.
